6 completed, 1 unknown. 3 Phase 4, 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow End-stage Renal Failure: new trials by email Literature Review of End-stage Renal Failure trials Research Report on End-stage Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The ONE Study UK Treg Trial Autologous regulatory T Cell Product - End-stage Renal Failure | Phase 1 / Phase 2 | Completed | Guy's and St Thomas' NHS Foundation Trust | 15 | 2014-04-01 | 2019-01-25 |
| Reference Group Trial for The ONE Study Blood drawing for immune monitoring and questionnaires - End-stage Renal Failure, Kidney Graft Rejection | Phase 4 | Completed | University of Regensburg | 70 | 2012-12-01 | 2016-03-09 |
| Safety and Dialysability of Dotarem® in Dialysed Patients Dotarem® IV injection at 0.1 mmol/kg - End-stage Renal Failure | Phase 1 | Completed | Guerbet | 10 | 2011-11-01 | 2015-07-08 |
| Mean Reticulated Haemoglobin (Hb) Content (RetHe) Analysis of Renal Patients End-Stage Renal Failure, Functional Iron Deficiency | Completed | University of Ulster | 250 | 2010-06-01 | 2018-11-30 | |
| Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation Tacrolimus (Kidney transplant maintenance immunosuppression), Kidney transplant maintenance immunosuppression - End-stage Renal Failure, Graft Rejection | Phase 4 | Completed | Imperial College Healthcare NHS Trust | 102 | 2008-12-01 | 2021-08-27 |
| Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients Spironolactone - End-stage Renal Failure | Phase 4 | Completed | Dialysis Outcomes Heart Failure Aldactone Study Group | 157 | 2008-04-01 | 2012-09-19 |
| Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia Biogeneric Epoetin - Chronic Kidney Disease, End-Stage Renal Failure | Phase 3 | Unknown | Ministry of Health, Malaysia | 2000 | 2005-08-01 | 2008-06-17 |
Kidney Failure, Chronic (7) · Anemia (1) · Iron Deficiencies (1) · Rejection, Psychology (1) · Renal Insufficiency, Chronic (1)
Chronic Disease (7) · Disease Attributes (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Kidney Diseases (7) · Male Urogenital Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Renal Insufficiency (7) · Urogenital Diseases (7) · Urologic Diseases (7) · Renal Insufficiency, Chronic (6) · Behavior (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
Blood Specimen Collection (1) · Monitoring, Immunologic (1) · Spironolactone (1) · Surveys and Questionnaires (1) · Tacrolimus (1) · gadoterate meglumine (1)
Dialysis Outcomes Heart Failure Aldactone Study Group (1) · Guerbet (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Imperial College Healthcare NHS Trust (1) · Ministry of Health, Malaysia (1) · University of Regensburg (1) · University of Ulster (1)
United Kingdom (3) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Malaysia (1) · United States (1)
Adam G McLean, MA DPhil (1) · Edward K. Geissler, Ph.D. (1) · Giovanna Lombardi, PhD (1) · Raymond Robson (1) · Sofie Mesens, MD (1)
PMID 32446407, PMID 24184249, PMID 33586138, PMID 36306921, PMID 36441083, PMID 39731908
2008 (1)